The global medical industry experienced a 53% drop in company filings mentions of corporate governance in Q3 2023 compared with the previous quarter, with the highest share accounted for by Agilent Technologies with 2671% year-on-year increase, according to GlobalData’s analysis of over 243 medical company filings. GlobalData’s Medical Devices: Filings Trends & Signals Q3 2023 report delves into earnings call transcripts and quarterly reports within the industry, extracting trends, signals, and comparative data to help businesses assess their performance, identify competitive intelligence, evaluate risks, and gain a comprehensive understanding of key industry events. Buy the report here.
Notably, corporate governance was one of the most frequently referenced themes in Q3 2023, ranking highest in terms of mentions, ahead of edge computing and precision and personalized medicine, according to GlobalData.
Of the top leading companies in the medical industry, Agilent Technologies had the greatest increase in references for corporate governance in Q3 2023, compared with the previous quarter. GlobalData identified 194 corporate governance-related sentences in the company's filings - 7% of all sentences - and an increase of 2671% in Q3 2023 compared with Q3 2022. Danaher’s mentions of corporate governance dropped by 2% to 165 and Becton Dickinson and Co’s by 3667% to 113 and Henry Schein’s by 36% to 113 and Bio-Techne’s by 7% to 112.
GlobalData’s Company Filings Analytics also applies sentiment weight to reference sentences, based on whether the sentences are positive, negative, or neutral. Starting at 100 in 2020, an index over 100 is more positive. The overall index for corporate governance in Q3 2023 was 107.
For further understanding of GlobalData's Medical Devices: Filings Trends & Signals Q3 2023, buy the report here.